{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:40:32Z","timestamp":1787002832179,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41423-020-00545-z","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T06:09:21Z","timestamp":1599804561000},"page":"2422-2430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Synthetic vitamin K analogs inhibit inflammation by targeting the NLRP3 inflammasome"],"prefix":"10.1038","volume":"18","author":[{"given":"Xicui","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingting","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3351-6420","authenticated-orcid":false,"given":"Rongbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9414-6902","authenticated-orcid":false,"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"545_CR1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.redox.2018.03.013","volume":"16","author":"D Ivanova","year":"2018","unstructured":"Ivanova, D. et al. Vitamin K: Redox-modulation, prevention of mitochondrial dysfunction and anticancer effect. Redox Biol. 16, 352\u2013358 (2018).","journal-title":"Redox Biol."},{"key":"545_CR2","doi-asserted-by":"publisher","first-page":"e000300","DOI":"10.1136\/openhrt-2015-000300","volume":"2","author":"JJ DiNicolantonio","year":"2015","unstructured":"DiNicolantonio, J. J., Bhutani, J. & O\u2019Keefe, J. H. The health benefits of vitamin K. Open Heart 2, e000300 (2015).","journal-title":"Open Heart"},{"key":"545_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1079\/BJN20051630","volume":"95","author":"HH Thijssen","year":"2006","unstructured":"Thijssen, H. H., Vervoort, L. M., Schurgers, L. J. & Shearer, M. J. Menadione is a metabolite of oral vitamin K. Br. J. Nutr. 95, 260\u2013266 (2006).","journal-title":"Br. J. Nutr."},{"key":"545_CR4","doi-asserted-by":"publisher","first-page":"33071","DOI":"10.1074\/jbc.M113.477356","volume":"288","author":"Y Hirota","year":"2013","unstructured":"Hirota, Y. et al. Menadione (vitamin K3) is a catabolic product of oral phylloquinone (vitamin K1) in the intestine and a circulating precursor of tissue menaquinone-4 (vitamin K2) in rats. J. Biol. Chem. 288, 33071\u201333080 (2013).","journal-title":"J. Biol. Chem."},{"key":"545_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1079\/BJN19940043","volume":"72","author":"HH Thijssen","year":"1994","unstructured":"Thijssen, H. H. & Drittij-Reijnders, M. J. Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4. Br. J. Nutr. 72, 415\u2013425 (1994).","journal-title":"Br. J. Nutr."},{"key":"545_CR6","first-page":"728","volume":"58","author":"M Rosati","year":"2017","unstructured":"Rosati, M. Saunders handbook of veterinary drugs: small and large animals. Can. Vet. J. 58, 728 (2017).","journal-title":"Can. Vet. J."},{"key":"545_CR7","first-page":"3","volume":"18","author":"L Wen","year":"2018","unstructured":"Wen, L., Chen, J., Duan, L. & Li, S. Vitamin Kdependent proteins involved in bone and cardiovascular health (Review). Mol. Med. Rep. 18, 3\u201315 (2018).","journal-title":"Mol. Med. Rep."},{"key":"545_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.diabres.2017.11.020","volume":"136","author":"Y Li","year":"2018","unstructured":"Li, Y., Chen, J. P., Duan, L. & Li, S. Effect of vitamin K2 on type 2 diabetes mellitus: a review. Diabetes Res. Clin. Pract. 136, 39\u201351 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"545_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep04768","volume":"4","author":"JK Nowak","year":"2014","unstructured":"Nowak, J. K. et al. Prevalence and correlates of vitamin K deficiency in children with inflammatory bowel disease. Sci. Rep. 4, 4768 (2014).","journal-title":"Sci. Rep."},{"key":"545_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/nu11010168","volume":"11","author":"M Cozzolino","year":"2019","unstructured":"Cozzolino, M. et al. Vitamin K in chronic kidney disease. Nutrients 11, 168 (2019).","journal-title":"Nutrients"},{"key":"545_CR11","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jnutbio.2009.09.011","volume":"21","author":"Y Ohsaki","year":"2010","unstructured":"Ohsaki, Y. et al. Vitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor kappaB through the repression of IKKalpha\/beta phosphorylation. J. Nutr. Biochem. 21, 1120\u20131126 (2010).","journal-title":"J. Nutr. Biochem."},{"key":"545_CR12","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1271\/bbb.70.926","volume":"70","author":"Y Ohsaki","year":"2006","unstructured":"Ohsaki, Y. et al. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci., Biotechnol., Biochem. 70, 926\u2013932 (2006).","journal-title":"Biosci., Biotechnol., Biochem."},{"key":"545_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.it.2018.01.009","volume":"39","author":"T Gong","year":"2018","unstructured":"Gong, T., Yang, Y., Jin, T., Jiang, W. & Zhou, R. Orchestration of NLRP3 inflammasome activation by ion fluxes. Trends Immunol. 39, 393\u2013406 (2018).","journal-title":"Trends Immunol."},{"key":"545_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.tibs.2018.06.008","volume":"43","author":"T Gong","year":"2018","unstructured":"Gong, T., Jiang, W. & Zhou, R. Control of inflammasome activation by phosphorylation. Trends Biochem Sci. 43, 685\u2013699 (2018).","journal-title":"Trends Biochem Sci."},{"key":"545_CR15","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.tips.2018.07.002","volume":"39","author":"T Tang","year":"2018","unstructured":"Tang, T., Gong, T., Jiang, W. & Zhou, R. GPCRs in NLRP3 inflammasome activation, regulation, and therapeutics. Trends Pharm. Sci. 39, 798\u2013811 (2018).","journal-title":"Trends Pharm. Sci."},{"key":"545_CR16","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/ni.3538","volume":"17","author":"L Mortimer","year":"2016","unstructured":"Mortimer, L., Moreau, F. & MacDonald, J. A. NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations. Nat. Immunol. 17, 1176\u20131186 (2016).","journal-title":"Nat. Immunol."},{"key":"545_CR17","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang, H. et al. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J. Exp. Med. 214, 3219\u20133238 (2017).","journal-title":"J. Exp. Med."},{"key":"545_CR18","doi-asserted-by":"publisher","first-page":"e8689","DOI":"10.15252\/emmm.201708689","volume":"10","author":"Y Huang","year":"2018","unstructured":"Huang, Y. et al. Tranilast directly targets NLRP3 to treat inflammasome-driven diseases. EMBO Mol. Med. 10, e8689 (2018).","journal-title":"EMBO Mol. Med."},{"key":"545_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04947-6","volume":"9","author":"H He","year":"2018","unstructured":"He, H. et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat. Commun. 9, 2550 (2018).","journal-title":"Nat. Commun."},{"key":"545_CR20","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","volume":"38","author":"Y Yan","year":"2013","unstructured":"Yan, Y. et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38, 1154\u20131163 (2013).","journal-title":"Immunity"},{"key":"545_CR21","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666\u2013671 (2015).","journal-title":"Nature"},{"key":"545_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117\u2013121 (2011).","journal-title":"Nature"},{"key":"545_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz, P. & Dixit, V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407\u2013420 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"545_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature13449","volume":"513","author":"H Xu","year":"2014","unstructured":"Xu, H. et al. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature 513, 237\u2013241 (2014).","journal-title":"Nature"},{"key":"545_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.molmed.2014.11.008","volume":"21","author":"P Gurung","year":"2015","unstructured":"Gurung, P., Lukens, J. R. & Kanneganti, T. D. Mitochondria: diversity in the regulation of the NLRP3 inflammasome. Trends Mol. Med. 21, 193\u2013201 (2015).","journal-title":"Trends Mol. Med."},{"key":"545_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","volume":"530","author":"Y He","year":"2016","unstructured":"He, Y., Zeng, M. Y., Yang, D., Motro, B. & Nunez, G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530, 354\u2013357 (2016).","journal-title":"Nature"},{"key":"545_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ni.3333","volume":"17","author":"H Shi","year":"2016","unstructured":"Shi, H. et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat. Immunol. 17, 250\u2013258 (2016).","journal-title":"Nat. Immunol."},{"key":"545_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson, K. V. & Deng, M. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19, 477\u2013489 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"545_CR29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","volume":"13","author":"AK So","year":"2017","unstructured":"So, A. K. & Martinon, F. Inflammation in gout: mechanisms and therapeutic targets. Nat. Rev. Rheumatol. 13, 639\u2013647 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"545_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1365-2249.2009.04083.x","volume":"160","author":"S Tanaka","year":"2010","unstructured":"Tanaka, S. et al. Vitamin K3 attenuates lipopolysaccharide-induced acute lung injury through inhibition of nuclear factor-kappaB activation. Clin. Exp. Immunol. 160, 283\u2013292 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"545_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s13668-016-0162-x","volume":"5","author":"SG Harshman","year":"2016","unstructured":"Harshman, S. G. & Shea, M. K. The role of vitamin K in chronic aging diseases: inflammation, cardiovascular disease, and osteoarthritis. Curr. Nutr. Rep. 5, 90\u201398 (2016).","journal-title":"Curr. Nutr. Rep."},{"key":"545_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1042\/cs0780063","volume":"78","author":"SJ Hodges","year":"1990","unstructured":"Hodges, S. J., Pilkington, M. J., Shearer, M. J., Bitensky, L. & Chayen, J. Age-related changes in the circulating levels of congeners of vitamin K2, menaquinone-7 and menaquinone-8. Clin. Sci. (Lond., Engl.: 1979). 78, 63\u201366 (1990).","journal-title":"Clin. Sci. (Lond., Engl.: 1979)."},{"key":"545_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.blre.2008.06.001","volume":"23","author":"MJ Shearer","year":"2009","unstructured":"Shearer, M. J. Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Rev. 23, 49\u201359 (2009).","journal-title":"Blood Rev."},{"key":"545_CR34","first-page":"531","volume":"17","author":"J Conly","year":"1994","unstructured":"Conly, J. & Stein, K. Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials. Clin. Invest. Med. Med. Clin. et. Exp. 17, 531\u2013539 (1994).","journal-title":"Clin. Invest. Med. Med. Clin. et. Exp."},{"key":"545_CR35","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00198-008-0764-2","volume":"20","author":"A Kuwabara","year":"2009","unstructured":"Kuwabara, A. et al. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos. Int. 20, 935\u2013942 (2009).","journal-title":"Osteoporos. Int."},{"key":"545_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.amjmed.2012.10.011","volume":"126","author":"D Misra","year":"2013","unstructured":"Misra, D. et al. Vitamin K deficiency is associated with incident knee osteoarthritis. Am. J. Med. 126, 243\u2013248 (2013).","journal-title":"Am. J. Med."},{"key":"545_CR37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1439-0396.2005.00558.x","volume":"89","author":"P Wolf","year":"2005","unstructured":"Wolf, P., Hupfeld, C., Dorrestein, G. & Kamphues, J. Investigations in pet birds (Agapornis spp.) fed different vitamin K contents in the diet. J. Anim. Physiol. Anim. Nutr. 89, 222\u2013228 (2005).","journal-title":"J. Anim. Physiol. Anim. Nutr."},{"key":"545_CR38","first-page":"129","volume":"52","author":"PC Ho","year":"1998","unstructured":"Ho, P. C. & Wong, V. K. Influence of DL methionine and sodium metabisulphite on the photostability of vitamin k1. PDA J. Pharm. Sci. Technol. 52, 129\u2013133 (1998).","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"545_CR39","doi-asserted-by":"crossref","unstructured":"Hassan G. S. Menadione. Profiles of Drug Substances, Excipients and Related Methodology. 227\u2013313, Vol. 38 (Elsevier; 2013).","DOI":"10.1016\/B978-0-12-407691-4.00006-X"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00545-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00545-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00545-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T04:33:08Z","timestamp":1632976388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-00545-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["545"],"URL":"https:\/\/doi.org\/10.1038\/s41423-020-00545-z","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"15 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}